vs
Global Indemnity Group, LLC（GBLI）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Global Indemnity Group, LLC的季度营收约是RIGEL PHARMACEUTICALS INC的1.7倍（$116.7M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 5.5%，领先378.5%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 7.6%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 2.0%）
Global Indemnity Group LLC是一家专业保险控股企业，提供定制化商业及个人财产意外险产品、保证保险与再保险解决方案，主要服务美国境内中小微企业及小众个人保险客群，聚焦传统保险覆盖不足的特殊风险领域。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
GBLI vs RIGL — 直观对比
营收规模更大
GBLI
是对方的1.7倍
$69.8M
营收增速更快
RIGL
高出13.6%
7.6%
净利率更高
RIGL
高出378.5%
5.5%
两年增速更快
RIGL
近两年复合增速
2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $116.7M | $69.8M |
| 净利润 | $6.5M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 7.9% | 33.2% |
| 净利率 | 5.5% | 384.0% |
| 营收同比 | 7.6% | 21.2% |
| 净利润同比 | -28.5% | 1769.2% |
| 每股收益（稀释后） | $0.48 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GBLIRIGL
| Q4 25 | $116.7M | $69.8M | ||
| Q3 25 | $114.2M | $69.5M | ||
| Q2 25 | $110.5M | $101.7M | ||
| Q1 25 | $108.7M | $53.3M | ||
| Q4 24 | $108.4M | $57.6M | ||
| Q3 24 | $111.8M | $55.3M | ||
| Q2 24 | $108.7M | $36.8M | ||
| Q1 24 | $112.3M | $29.5M |
净利润GBLIRIGL
| Q4 25 | $6.5M | $268.1M | ||
| Q3 25 | $12.5M | $27.9M | ||
| Q2 25 | $10.3M | $59.6M | ||
| Q1 25 | $-4.0M | $11.4M | ||
| Q4 24 | $9.0M | $14.3M | ||
| Q3 24 | $12.8M | $12.4M | ||
| Q2 24 | $10.1M | $-1.0M | ||
| Q1 24 | $11.4M | $-8.2M |
毛利率GBLIRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率GBLIRIGL
| Q4 25 | 7.9% | 33.2% | ||
| Q3 25 | 14.1% | 40.9% | ||
| Q2 25 | 11.9% | 60.1% | ||
| Q1 25 | -4.7% | 23.9% | ||
| Q4 24 | 11.2% | 28.9% | ||
| Q3 24 | 14.2% | 25.4% | ||
| Q2 24 | 11.7% | 1.2% | ||
| Q1 24 | 12.7% | -23.6% |
净利率GBLIRIGL
| Q4 25 | 5.5% | 384.0% | ||
| Q3 25 | 11.0% | 40.2% | ||
| Q2 25 | 9.4% | 58.6% | ||
| Q1 25 | -3.7% | 21.5% | ||
| Q4 24 | 8.3% | 24.9% | ||
| Q3 24 | 11.4% | 22.5% | ||
| Q2 24 | 9.3% | -2.8% | ||
| Q1 24 | 10.1% | -27.9% |
每股收益（稀释后）GBLIRIGL
| Q4 25 | $0.48 | $14.11 | ||
| Q3 25 | $0.86 | $1.46 | ||
| Q2 25 | $0.71 | $3.28 | ||
| Q1 25 | $-0.30 | $0.63 | ||
| Q4 24 | $0.65 | $0.82 | ||
| Q3 24 | $0.92 | $0.70 | ||
| Q2 24 | $0.73 | $-0.06 | ||
| Q1 24 | $0.82 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $65.5M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $706.6M | $391.5M |
| 总资产 | $1.7B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资GBLIRIGL
| Q4 25 | $65.5M | $155.0M | ||
| Q3 25 | $75.4M | $137.1M | ||
| Q2 25 | $67.3M | $108.4M | ||
| Q1 25 | $81.1M | $77.1M | ||
| Q4 24 | $17.0M | $77.3M | ||
| Q3 24 | $31.0M | $61.1M | ||
| Q2 24 | $46.7M | $49.1M | ||
| Q1 24 | $38.9M | $49.5M |
总债务GBLIRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益GBLIRIGL
| Q4 25 | $706.6M | $391.5M | ||
| Q3 25 | $704.1M | $117.6M | ||
| Q2 25 | $695.3M | $81.9M | ||
| Q1 25 | $687.1M | $18.6M | ||
| Q4 24 | $689.1M | $3.3M | ||
| Q3 24 | $686.7M | $-14.6M | ||
| Q2 24 | $667.5M | $-29.9M | ||
| Q1 24 | $659.5M | $-31.7M |
总资产GBLIRIGL
| Q4 25 | $1.7B | $513.6M | ||
| Q3 25 | $1.7B | $242.5M | ||
| Q2 25 | $1.7B | $206.7M | ||
| Q1 25 | $1.7B | $176.0M | ||
| Q4 24 | $1.7B | $164.0M | ||
| Q3 24 | $1.8B | $139.4M | ||
| Q2 24 | $1.7B | $128.4M | ||
| Q1 24 | $1.7B | $126.5M |
负债/权益比GBLIRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.1M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.40× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流GBLIRIGL
| Q4 25 | $9.1M | $22.0M | ||
| Q3 25 | $5.7M | $24.0M | ||
| Q2 25 | $7.0M | $30.5M | ||
| Q1 25 | $2.4M | $-893.0K | ||
| Q4 24 | $38.8M | $14.5M | ||
| Q3 24 | $15.3M | $21.7M | ||
| Q2 24 | $14.3M | $302.0K | ||
| Q1 24 | $22.7M | $-5.0M |
现金转化率GBLIRIGL
| Q4 25 | 1.40× | 0.08× | ||
| Q3 25 | 0.45× | 0.86× | ||
| Q2 25 | 0.68× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | 4.30× | 1.01× | ||
| Q3 24 | 1.20× | 1.75× | ||
| Q2 24 | 1.41× | — | ||
| Q1 24 | 2.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GBLI
| Belmont Core | $99.2M | 85% |
| Agency And Insurance Services | $13.8M | 12% |
| Other | $3.7M | 3% |
RIGL
暂无分部数据
